Unit Head for the High Throughput Biomedicine unit

Location

Ihe Institute for Molecular Medicine Finland (FIMM) is an international research institute focusing on human genomics and personalised medicine at the University of Helsinki. In the beginning of 2017 FIMM joined the University of Helsinki’s new life science research centre, Helsinki Institute of Life Science HiLIFE, as an operational unit. FIMM integrates molecular medicine research, technology centre and biobanking infrastructures under one roof, promoting translational research in grand challenge projects, specifically, the impact of genome information from the Finnish population in personalised health and medicine, individualised cancer medicine, and digital molecular medicine. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark, and the EU-LIFE Community.

Technology Centre is currently seeking for a senior researcher to act as

Head for the High Throughput Biomedicine unit

 

The High Throughput Biomedicine (HTB) unit of the FIMM Technology Centre performs high throughput bioassays, cell-based drug screening and RNAi experiments. The unit supports research at the University of Helsinki and functions as a national and international infrastructure platform mainly for academic researchers. We are currently looking for a Unit Head.

  • The primary activities of the position include, but are not limited to:
  • Networking and acquiring new projects
  • Developing the unit’s strategy together with the director of the FIMM TC, unit staff, and unit’s user advisory panel
  • Establishing and participating national and international collaborations
  • Applying for national and international grants, grant reporting
  • Responsibility of unit finances

Qualification and experience:

Qualification requirements include an MD/PhD, PhD or equivalent degree, postdoctoral training, project management, method development, and a strong publication record in the field. International mobility, such as training in high-quality institutions and universities globally will be valued as wells as a wide personal network in the research area. We expect that the Unit Head will engage in multidisciplinary research collaborations with other FIMM research groups, and with the life science community in Helsinki. Translational focus towards diagnostics and personalized medicine is valued along with the possibility of providing additional and novel contributions to existing FIMM and Meilahti campus research groups.

Candidates should have a strong background in research and high throughput screening and proven experience with at least: industrial collaborations, project management and coordination, and supervision of personnel. Prior experience with drug sensitivity testing as well as industry/company experience, will be valued. The successful candidate is expected to have excellent problem solving, organizational, and analytical skills, and is able to work systematically. In addition, the candidate should be fluent in English, have good interpersonal and communication skills, and modern leadership skills.

Salary & contract:

The salary will be commensurate with qualifications based on the university salary system. A contract will be offered initially until 31.12.2020. Extension beyond this is possible depending on the performance.

To apply for the position, please send your motivation letter and CV, including list of publications and contact information for two references, through the University of Helsinki electronic recruitment system by clicking on the Apply link. Internal applicants (i.e., current employees of the University of Helsinki) please submit your applications through the SAP HR portal. Selection of candidates will commence on 31.10.2017. The employment may begin as soon as possible or as agreed. For further information please visit our website at http://www.fimm.fi or contact Krister Wennerberg (krister.wennerberg@helsinki.fi) or Jani Saarela (jani.saarela@helsinki.fi).

 

Last updated: 11.10.2017 - 10:18